Bronkofylin 169.4mg/50.6mg Injection
Marketer
Indus Pharma Pvt Ltd
Salt Composition
Etofylline (169.4mg) + Theophylline (50.6mg)
Overview Bronkofylin 169.4mg/50.6mg Injection
AirDuo RespiClick 169.4mg/50.6mg injection provides relief from asthma and chronic obstructive pulmonary disease (COPD), a lung condition characterized by restricted airflow. This medication relaxes airway muscles, facilitating easier breathing. Administration is by a physician or registered nurse, with dosage tailored to individual needs and response. Continuous use, as directed by your doctor, is crucial; premature discontinuation may lead to symptom recurrence and disease progression. Inform your healthcare provider of all other medications you're using, as potential drug interactions exist. Common, usually transient side effects include nausea, vomiting, indigestion, headache, and agitation. Report any concerns regarding side effects immediately. Prior to treatment, disclose any pre-existing heart, kidney, or liver conditions to ensure appropriate dosage. Similarly, inform your doctor if you are pregnant, considering pregnancy, or breastfeeding.
Uses of Bronkofylin 169.4mg/50.6mg Injection
Managing chronic obstructive pulmonary disease (COPD)
Major Benefits of Bronkofylin 169.4mg/50.6mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Bronkofylin 169.4mg/50.6mg Injection:
- Nausea
- Vomiting
- Headache
- Restlessness
How to use Bronkofylin 169.4mg/50.6mg Injection:
This medication will be administered by your healthcare provider. Self-medication is not permitted.
How Bronkofylin 169.4mg/50.6mg Injection works:
Etofylline and theophylline, combined as Bronkofylin Injection (169.4mg/50.6mg), act as bronchodilators. Their mechanism involves airway muscle relaxation, leading to widened airways and improved breathing.
SAFETY ADVICE
AlcoholUNSAFE
Combining Bronkofylin 169.4mg/50.6mg Injection with alcohol is unsafe.
PregnancyCONSULT YOUR DOCTOR
Use of Bronkofylin 169.4mg/50.6mg Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any possible risks prior to prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
The administration of Bronkofylin 169.4mg/50.6mg Injection is considered safe for breastfeeding mothers. Research in humans indicates minimal drug transfer into breast milk, posing no appreciable risk to the infant. Post-injection, a 2-4 hour delay in breastfeeding may further reduce infant drug exposure.
DrivingCONSULT YOUR DOCTOR
The effect of Bronkofylin 169.4mg/50.6mg Injection on driving ability is undetermined. Refrain from operating a vehicle if you exhibit symptoms impairing concentration or reaction time.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Bronkofylin 169.4mg/50.6mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
Administering Bronkofylin 169.4mg/50.6mg Injection requires careful consideration in individuals with hepatic impairment. Dosage modification for Bronkofylin 169.4mg/50.6mg Injection may be necessary. Physician consultation is advised.
What if you forget to take Bronkofylin 169.4mg/50.6mg Injection :
Should you inadvertently skip a Bronkofylin 169.4mg/50.6mg Injection dose, seek medical advice immediately.
Facts to Know About Bronkofylin 169.4mg/50.6mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Breathing |
3,018 People bought this recently